These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Healthcare resource utilization and direct medical costs associated with index and recurrent Clostridioides difficile infection: a real-world data analysis. Feuerstadt P, Stong L, Dahdal DN, Sacks N, Lang K, Nelson WW. J Med Econ; 2020 Jun; 23(6):603-609. PubMed ID: 31999199 [Abstract] [Full Text] [Related]
3. Mortality, Health Care Use, and Costs of Clostridioides difficile Infections in Older Adults. Feuerstadt P, Nelson WW, Drozd EM, Dreyfus J, Dahdal DN, Wong AC, Mohammadi I, Teigland C, Amin A. J Am Med Dir Assoc; 2022 Oct; 23(10):1721-1728.e19. PubMed ID: 35288083 [Abstract] [Full Text] [Related]
4. Clinical burden of recurrent Clostridioides difficile infection in the medicare population: A real-world claims analysis. Feuerstadt P, Nelson WW, Teigland C, Dahdal DN. Antimicrob Steward Healthc Epidemiol; 2022 Oct; 2(1):e60. PubMed ID: 36483433 [Abstract] [Full Text] [Related]
7. Attributable Healthcare Resource Utilization and Costs for Patients With Primary and Recurrent Clostridium difficile Infection in the United States. Zhang D, Prabhu VS, Marcella SW. Clin Infect Dis; 2018 Apr 17; 66(9):1326-1332. PubMed ID: 29360950 [Abstract] [Full Text] [Related]
8. Economic Impact of Recurrent Clostridioides difficile Infection in the USA: A Systematic Literature Review and Cost Synthesis. Reveles KR, Yang M, Garcia-Horton V, Edwards ML, Guo A, Lodise T, Bochan M, Tillotson G, Dubberke ER. Adv Ther; 2023 Jul 17; 40(7):3104-3134. PubMed ID: 37210680 [Abstract] [Full Text] [Related]
11. Economic and Clinical Burden of Acute Myeloid Leukemia Episodes of Care in the United States: A Retrospective Analysis of a Commercial Payer Database. Pandya BJ, Chen CC, Medeiros BC, McGuiness CB, Wilson SD, Walsh EH, Wade RL. J Manag Care Spec Pharm; 2020 Jul 17; 26(7):849-859. PubMed ID: 32281456 [Abstract] [Full Text] [Related]
12. Epidemiological and clinical burden of Clostridioides difficile infections and recurrences between 2015 - 2019: the RECUR Germany study. Tricotel A, Antunes A, Wilk A, Dombrowski S, Rinta-Kokko H, Andersson FL, Ghosh S. BMC Infect Dis; 2024 Mar 27; 24(1):357. PubMed ID: 38539166 [Abstract] [Full Text] [Related]
13. Predictors and burden of hospital readmission with recurrent Clostridioides difficile infection: a French nation-wide inception cohort study. Dinh A, Le Monnier A, Emery C, Alami S, Torreton É, Duburcq A, Barbier F. Eur J Clin Microbiol Infect Dis; 2019 Jul 27; 38(7):1297-1305. PubMed ID: 30941532 [Abstract] [Full Text] [Related]
17. Impact of Pain Severity and Opioid Use on Health Care Resource Utilization and Costs Among Patients with Knee and Hip Osteoarthritis. Wei W, Gandhi K, Blauer-Peterson C, Johnson J. J Manag Care Spec Pharm; 2019 Sep 27; 25(9):957-965. PubMed ID: 31456495 [Abstract] [Full Text] [Related]
19. Burden of Clostridium difficile-associated disease among patients residing in nursing homes: a population-based cohort study. Yu H, Baser O, Wang L. BMC Geriatr; 2016 Nov 25; 16(1):193. PubMed ID: 27884118 [Abstract] [Full Text] [Related]